SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Wednesday reported a loss of $69.4 million in its fourth quarter.
The Seattle-based company said it had a loss of 48 cents per share. Losses, adjusted for asset impairment costs, came to 30 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The life-sciences research company posted revenue of $45.8 million in the period, which missed Street forecasts. Five analysts surveyed by Zacks expected $50.1 million.
For the year, the company reported that its loss widened to $225.3 million, or $1.56 per share. Revenue was reported as $170.3 million.
In the final minutes of trading on Wednesday, the company's shares hit $3.93. A year ago, they were trading at $8.68.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT